Finnish biology inventors selected as finalists for the European Inventor Award 2024
The husband-and-wife team, Sirpa and Markku Jalkanen, developed a clinical treatment to activate the immune system in fighting cancer cells. They were selected from over 550 candidates as finalists in the ‘SMEs’ category of the European Inventor Award 2024, competing against a French team and a Polish one. The winners will be announced during the ceremony on 9 July in Malta.Igniting the immune system to target cancer Bexmarilimab, the drug developed by this husband-and-wife team, better equips the immune system to fight cancer cells, making it a form of immunotherapy, which is an